APA (7th ed.) Citation

Yamaguchi, M., Asano, T., Arisaka, T., Mashima, H., Irisawa, A., & Tamano, M. (2022). Effects of pemafibrate on primary biliary cholangitis with dyslipidemia. Hepatology research, 52(6), 522-531. https://doi.org/10.1111/hepr.13747

Chicago Style (17th ed.) Citation

Yamaguchi, Mayumi, Takeharu Asano, Takahiro Arisaka, Hirosato Mashima, Atsushi Irisawa, and Masaya Tamano. "Effects of Pemafibrate on Primary Biliary Cholangitis with Dyslipidemia." Hepatology Research 52, no. 6 (2022): 522-531. https://doi.org/10.1111/hepr.13747.

MLA (9th ed.) Citation

Yamaguchi, Mayumi, et al. "Effects of Pemafibrate on Primary Biliary Cholangitis with Dyslipidemia." Hepatology Research, vol. 52, no. 6, 2022, pp. 522-531, https://doi.org/10.1111/hepr.13747.